Menu
- Home
+ - Publications
+
- Archives
+
- BCIQ
+
- Conferences
+
- eLearning
+
- Follow Us
Latest News
4:06 PM Dec 14, 2018
Shanghai Henlius up for Hong Kong IPO
Biosimilars company Shanghai Henlius Biotech Inc. (Shanghai, China) proposed on Friday to list on the Hong...
4:04 PM Dec 14, 2018
Firdapse re-catalyzes pricing debate
A decision by Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) to charge $375,000 a year for Firdapse...
4:04 PM Dec 14, 2018
J&J shares plummet following asbestos report
Johnson & Johnson (NYSE:JNJ) fell $14.84 (10%) to $133 on Friday, wiping out nearly $40 billion in...
4:02 PM Dec 14, 2018
BIO, PhRMA look to U.S.-Japan trade talks to shape pricing reforms
Forthcoming U.S-Japan trade negotiations could provide industry trade groups BIO and PhRMA a mechanism to...
3:39 PM Dec 14, 2018
FDA approves Celltrion's Herceptin biosimilar
FDA approved a BLA for Herceptin biosimilar Herzuma trastuzumab-pkrb from Celltrion Inc. (KOSDAQ:068270)...
3:37 PM Dec 14, 2018
Amgen pulls out of Advaxis immunotherapy deal
Advaxis Inc. (NASDAQ:ADXS) will continue to enroll patients in a Phase I trial of its ADXS-NEO program...
3:22 PM Dec 14, 2018
CHMP backs Besremi for polycythemia vera, two Shionogi drugs
EMA's CHMP recommended a basket of approvals and label extensions on Friday, including Orphan Drug Besremi...
2:38 PM Dec 14, 2018
Idera down on melanoma response data
Idera Pharmaceuticals Inc. (NASDAQ:IDRA) lost $2.62 (40%) to $3.98 on Friday after reporting updated data...
1:36 PM Dec 14, 2018
FDA approves Shire's constipation drug
FDA approved Motegrity prucalopride from Shire plc (LSE:SHP; NASDAQ:SHPG) to treat chronic idiopathic...
1:30 PM Dec 14, 2018
More aboard for Amsterdam as EMA staffing outlook improves
More EMA staff may make the move to Amsterdam than the agency forecast this summer, but staff losses will...
1:28 PM Dec 14, 2018
Carter to fill Decicco's role until BMS finds new discovery head
With former head of discovery Carl Decicco gone, Bristol-Myers Squibb Co. (NYSE:BMY) will turn to Head of...
7:40 AM Dec 14, 2018
Kurma announces first close of €150 million Biofund III
Kurma Partners S.A. completed the first close of its third fund, Kurma Biofund III, which is targeting a...
3:44 PM Dec 13, 2018
NIH finds 'systematic' foreign theft of U.S. research due to lax disclosure rules
NIH's Foreign Influences on Research Integrity Working Group has identified specific instances of foreign...
3:34 PM Dec 13, 2018
Biogen returns gene therapies to AGTC on lack of clinical activity
Applied Genetic Technologies Corp. (NASDAQ:AGTC) said late Wednesday that Biogen Inc. (NASDAQ:BIIB)...
3:28 PM Dec 13, 2018
Senate bill could give HHS teeth to stop excessive drug price hikes
Democrat senators introduced a bill Thursday that would give HHS power to force drugmakers to pay back...
2:24 PM Dec 13, 2018
Management tracks: Ambys, Foghorn
Liver regenerative medicine company Ambys Medicines (Redwood City, Calif.) hired Jeff Jonker as president,...
11:58 AM Dec 13, 2018
U.S., Chinese academies planning meeting to set strict germline gene editing standards
The U.S. National Academy of Sciences, U.S. National Academy of Medicine and Chinese Academy of Sciences...
10:37 AM Dec 13, 2018
Biohaven nets $125M ahead of NDA submissions
Biohaven Pharmaceutical Holding Co. Ltd. (NYSE:BHNV) raised $125 million late Wednesday through the sale...
9:47 AM Dec 13, 2018
Junshi IPO on deck in Hong Kong as WuXi AppTec shares debut
Shares of WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) were unchanged in their first day of trading...
9:00 AM Dec 13, 2018
Mission Bio raises $30M series B to expand Tapestri’s reach
Precision genomics company Mission Bio Inc. (South San Francisco, Calif.) raised $30 million in an...
About Biocentury
Contact
Support
Products & Solutions
Legal
- Follow Us
What is BioCentury?
BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.